cDNA Array Analysis of SPARC-modulated Changes in Glioma Gene Expression
暂无分享,去创建一个
[1] S. Rempel,et al. Molecular biology of nervous system tumors. , 2001, Hematology/oncology clinics of North America.
[2] A. Nakeff,et al. SPARC Modulates Cell Growth, Attachment and Migration of U87 Glioma Cells on Brain Extracellular Matrix Proteins , 2001, Journal of Neuro-Oncology.
[3] E. Sage,et al. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. , 2001, The Journal of clinical investigation.
[4] Tohru Kimura,et al. Alteration of cell adhesion and cell cycle properties of ES cells by an inducible dominant interfering Myb mutant , 2001, Oncogene.
[5] M. Kurrer,et al. Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. , 2000, Cancer research.
[6] S. Rempel,et al. A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC secretion correlates with decreased migration on vitronectin. , 2000, International journal of oncology.
[7] J. Tonn,et al. Targeting angiogenesis inhibits tumor infiltration and expression of the pro‐invasive protein SPARC , 2000, International journal of cancer.
[8] R L Vessella,et al. Differential expression of osteonectin/SPARC during human prostate cancer progression. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] H. J. Kim,et al. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. , 2000, The Biochemical journal.
[10] M. Webber,et al. Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. , 1999, Cancer research.
[11] T. Mikkelsen,et al. Increased SPARC expression promotes U87 glioblastoma invasion in vitro , 1999, International Journal of Developmental Neuroscience.
[12] E. Sage,et al. Cell cycle‐dependent nuclear location of the matricellular protein SPARC: Association with the nuclear matrix , 1999, Journal of cellular biochemistry.
[13] S. Rempel,et al. SPARC: a potential diagnostic marker of invasive meningiomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[14] T. Mikkelsen,et al. SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. , 1998, Journal of neuropathology and experimental neurology.
[15] Jean-Michel,et al. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. , 1998, Cancer research.
[16] J. A. Greenwood,et al. Signaling of de‐adhesion in cellular regulation and motility , 1998, Microscopy research and technique.
[17] X. Zhang,et al. [The expression of plasminogen activator inhibitor-1 (PAI-1) gene in human astrocytomas]. , 1998, Zhonghua bing li xue za zhi = Chinese journal of pathology.
[18] E. Sage,et al. SPARC (BM-40, Osteonectin) Inhibits the Mitogenic Effect of Vascular Endothelial Growth Factor on Microvascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[19] B. Trask,et al. Complete physical map of the common deletion region in Williams syndrome and identification and characterization of three novel genes , 1998, Human Genetics.
[20] B. Nordlinger,et al. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[21] D. Greenspan,et al. Transforming Growth Factor-β Regulation of Bone Morphogenetic Protein-1/Procollagen C-proteinase and Related Proteins in Fibrogenic Cells and Keratinocytes* , 1997, The Journal of Biological Chemistry.
[22] A. Ullrich,et al. Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site , 1997, Oncogene.
[23] R. Timpl,et al. Limited Cleavage of Extracellular Matrix Protein BM-40 by Matrix Metalloproteinases Increases Its Affinity for Collagens* , 1997, The Journal of Biological Chemistry.
[24] O. Podhajcer,et al. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells , 1997, Nature Medicine.
[25] S. Coons,et al. Dichotomy of astrocytoma migration and proliferation , 1996, International journal of cancer.
[26] P. Chambon,et al. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin‐3 and BM‐40/SPARC genes , 1995, International journal of cancer.
[27] G. Lyons,et al. Bone morphogenetic protein-1 and a mammalian tolloid homologue (mTld) are encoded by alternatively spliced transcripts which are differentially expressed in some tissues. , 1994, The Journal of biological chemistry.
[28] Hans Marquardt,et al. βig-h3: A Transforming Growth Factor-β-Responsive Gene Encoding a Secreted Protein That Inhibits Cell Attachment In Vitro and Suppresses the Growth of CHO Cells in Nude Mice , 1994 .
[29] M. Reed,et al. Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[30] E. Sage,et al. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts , 1993, Journal of cellular physiology.
[31] M. Iruela-Arispe,et al. Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1. , 1992, The Journal of biological chemistry.
[32] E. Sage,et al. SPARC antagonizes the effect of basic fibroblast growth factor on the igration of bovine aortic endothelial cells , 1992, Journal of cellular biochemistry.
[33] R. Ross,et al. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[34] S. Mundlos,et al. Distribution of osteonectin mRNA and protein during human embryonic and fetal development. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[35] E. Sage,et al. SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells. , 1991, The Journal of biological chemistry.
[36] Webster K. Cavenee,et al. Pathology and genetics of tumours of the nervous system. , 2000 .